Cardiac conduction system (CCS)

The *cardiac conduction system* is a specialized network within the heart composed primarily of modified cardiac muscle cells that generate and propagate electrical impulses essential for coordinated heartbeat initiation and timing. Its main components are: 1. The sinoatrial (SA) node – located in the right atrium near the superior vena cava junction; serves as the primary physiological pacemaker generating spontaneous action potentials approximately 60–100 times per minute under normal conditions. 2. Internodal pathways – conduct impulses from SA node through atrial myocardium. 3. The atrioventricular (AV) node – located at interatrial septum near tricuspid valve; acts as secondary pacemaker with slower intrinsic rate but delays impulse transmission briefly allowing ventricular filling. 4. Bundle of His – conducts impulses from AV node into interventricular septum. 5. Right and left bundle branches – carry signals down respective sides toward apex. 6. Purkinje fibers – rapidly distribute impulse throughout ventricular myocardium causing synchronized contraction. This hierarchical sequence ensures efficient pumping function with atrial contraction preceding ventricular contraction.[1][3] At molecular level, automaticity arises from ionic currents mediated notably by hyperpolarization activated cyclic nucleotide gated channel type IV protein (*HCN4*) producing funny current (*I_f*) responsible for diastolic depolarization phase in nodal cells.[6] Developmentally regulated transcription factors such as TBX3 maintain conductive phenotype distinct from working myocardium.[2][4] Clinically significant disorders arise when any part malfunctions causing arrhythmias requiring pharmacologic modulation or device therapy.[8]

Other names

Heart's electrical conduction systemCardiac electrical conduction pathwayHeart's pacemaker system (informal)

Mechanisms relevant for drugs acting on elements within the CCS include: Modulation of ion channels controlling automaticity/pacemaking currents (*I_f* current via HCN4 channel); Alteration of calcium handling influencing depolarization cycles in nodal cells; Autonomic modulation altering firing rates at SA/AV nodes. Drugs act by slowing down/up regulating impulse generation/conduction velocity within this network but do not "target" CCS molecules directly as one entity.